However, two meta-analyses indicated that PTEN was a favorable prognostic factor for patients with ccRCC (Que et al., 2018; Tang et al., 2017), which is consistent with our findings. The gene discussed is PTEN; the disease is nonpapillary renal cell carcinoma.